The DOI matches its Crossref record; 58 of the 61 references it cites were found in a registry or an index.
BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function
Open accessAbstract
BRCA1 interacts in vivo with a novel protein, BACH1, a member of the DEAH helicase family. BACH1 binds directly to the BRCT repeats of BRCA1. A BACH1 derivative, bearing a mutation in a residue that was essential for catalytic function in other helicases, interfered with normal double-strand break repair in a manner that was dependent on its BRCA1 binding function. Thus, BACH1/BRCA1 complex formation contributes to a key BRCA1 activity. In addition, germline BACH1 mutations affecting the helicase domain were detected in two early-onset breast cancer patients and not in 200 matched controls. Thus, it is conceivable that, like BRCA1, BACH1 is a target of germline cancer-inducing mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The purified 130-kDa protein was subject to tandem mass spectrometry and the FANCJ gene was cloned and found to consist of 20 exons spanning greater than 180 kb of genomic sequence in chromosome 17q22.”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“Furthermore, unlike the classic paradigm for tumor suppressor genes, in which the tumor exclusively lacks the wild-type allele, tumors of individuals who were heterozygous for these two germline FANCJ mutations did not show loss of the corresponding wild-type allele [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“For example, the P47A variant identified in 2001 [8] and shown to disrupt FANCJ enzyme function [56] was found in the controls of a subsequent study and considered to be unrelated to breast cancer [44].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“Among the proteins identified was a protein of approximately 130 kDa that failed to interact with a BRCA1, harboring patient mutations within the BRCT motifs (P1749R and M1775R) [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“Most notably, the protein product had strong homology to the catalytic and nucleotide-binding domains of other members within the DEAH helicase family, including the xeroderma pigmentosum complimenting group D (XPD) [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“In keeping with this suggestion, two patients with a family history and early-onset breast cancer were identified that had discrete germline sequence changes, P47A and M299I, targeting the helicase domain of FANCJ [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“Moreover, the aforementioned P47A mutant had a reduced protein half-life when overexpressed in tissue culture cells [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“In particular, overexpression of the helicase-inactive K52R mutant in cells with wild-type FANCJ resulted in the accumulation of unrepaired DNA breaks when analyzed by pulse field electrophoresis [8], as well as reduced homologous recombination following double strand break induction [69].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“BRCA1 clinical mutations target the BRCT region required for FANCJ binding [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
High-Efficiency Transformation of Mammalian Cells by Plasmid DNA
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,327
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Self-citationBrca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Carney, J. P., Maser, R. S., Olivares, H., Davis, E. M., Le Beau, M., Yates, J. R., Hays, L., Morgan, W. F., & Petrini, J. H. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81175-7 · Cited by 1,226
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221
Stewart, G. S., Maser, R. S., Stankovic, T., Bressan, D. A., Kaplan, M. I., Jaspers, N. G. J., Raams, A., Byrd, P. J., Petrini, J. H. J., & Taylor, A. M. R. (1999) · Cell · doi:10.1016/s0092-8674(00)81547-0 · Cited by 1,060
Eckner, R., Ewen, M. E., Newsome, D., Gerdes, M., DeCaprio, J. A., Lawrence, J. B., & Livingston, D. M. (1994) · Genes & Development · doi:10.1101/gad.8.8.869 · Cited by 1,045
Self-citationDynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80503-6 · Cited by 900
Self-citation
Research works printed but not linked: 1
- Ma, 1994, Mutational analysis of ERCC3, which is involved in DNA repair and transcription initiation, Mol. Cell. Biol., 14, 4126, 10.1128/MCB.14.6.4126 · DOI
Cited by
Sorted by citations
Items 601–676 of 676
DNA helicases in recombination
Klein, H. L. (2007) · Springer eBooks · doi:10.1007/978-3-540-71021-9_5
The Fanconi anemia DNA maintenance pathway: focus on the FANCE and FANCF proteins
Léveillé, F. (2006) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Shen, X., Yang, Y., Wang, Y., Chen, X., Yang, J., & He, T. (2014) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2014.6999277
SURVEY AND SUMMARY DNA helicase and helicase–nuclease enzymes with a conserved iron–sulfur cluster
Wu, Y., & Brosh, R. M. (2011)
de Sousa, J. F., Cristofaro, L. F. D., Serafim, R. B., Netto, R. P., Souza, F. O., Soares, C. P., & Valente, V. (2015) · DOAJ (DOAJ: Directory of Open Access Journals)
The Role of BRCA1 and BRCA2 in Anticancer Drug Therapy
Shuen, A. Y., Reis-Filho, J. S., & Foulkes, W. D. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4741-2_6
The Q motif is involved in DNA binding that affects ATP hydrolysis and unwinding in ChlR1 helicase
Ding, H. (2016) · University Library - University of Saskatchewan (University of Saskatchewan)
Mitchell, A. H. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35073024
Fang, H., Wu, Y., Yoon, M. S., Jiménez-Barrón, L. T., O'Rawe, J., Highnam, G., Mittelman, D., & Lyon, G. J. (2015) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/019182
The Ras effector NORE1A forms a tumor suppressor complex with BRCA1.
Nelson, N. C. (2015) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2336
A DNA-damage Response Network of Fanconi Anemia and BRCA Proteins
Guo, R., & Wang, W. (2007) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789812706782_0007
Taniguchi, T., Dhillon, K. K., Castellà, M., Cheung, R. S., & Jacquemont, C. F. (2012) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814355698_0006
A Swiss army knife of DNA interstrand crosslink repair
Cybulski, K. E., & Howlett, N. G. (2011)
Susceptibility genes in hereditary breast cancer
Vahteristo, P. (2003) · Työväentutkimus Vuosikirja
Genomic Profiling of Familial Early-Age of Onset Breast Cancer
Seto, A. J. (2015) · TSpace (University of Toronto)
Carney, S. M. (2016) · D-Scholarship@Pitt (University of Pittsburgh)
Nitric oxide cytotoxicity and functions of iron-sulfur enzymes in Escherichia coli
Ren, B. (2009) · Louisiana State University · doi:10.31390/gradschool_dissertations.3786
Meta-Analysis of Association Between BRIP1 Polymorphisms and Breast Cancer Risk
Dianatpour, A., Faramarzi, S., & Ghafouri‐Fard, S. (2019) · International Journal of Cancer Management · doi:10.5812/ijcm.84234
Understanding the biological functions of POPX2 phosphatase through its interactome
Kim, P. (2019) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/136952
Bermisheva, M., Gilyazova, I. R., Zinnatullina, G., & Хуснутдинова, Э. К. (2020) · Russian Journal of Genetics · doi:10.1134/s1022795420050026
Genes Involved in the Cisplatin Response of BRCA2 Cancers
Rose, J. M. (2012) · Digital WPI
Panorama genético do carcinoma epidermóide de pênis
de Lucca, R. M. R. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2020.tde-03112020-120145
FancJ Acetylation as a DNA Damage Response
Quan, S. (2012) · Digital WPI
(2013) · CRC Press eBooks · doi:10.1201/b14587-15
Cantor, S. B., Sellers, W. R., Pathania, S., & Greenberg, R. A. (2022) · Molecular Cell · doi:10.1016/j.molcel.2021.12.013
Self-citationManaging DNA Strand Breaks in Eukaryotic Cells
Friedberg, E. C., Walker, G. C., Siede, W., Wood, R. D., Schultz, R. A., & Ellenberger, T. (2014) · ASM Press eBooks · doi:10.1128/9781555816704.ch18
Tóth, Á. (2021) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.10661
Katheeja Muhseena, N., Das, S. P., & Laha, S. (2021) · Research Square · doi:10.21203/rs.3.rs-151524/v1
Georgakilas, A. G. (2012) · CRC Press eBooks · doi:10.1201/b14318-7
Identifying vulnerabilities of chromosomal instability
Janssen, L. M. E. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/767
Choi, Y. J., Kim, B., Kim, Y., Shin, S., & Lee, K. (2022) · Laboratory Medicine Online · doi:10.47429/lmo.2022.12.3.145
Zhao, Y., Tabet, D. R., Rubio-Contreras, D., Kousholt, A. N., Weile, J., Melo, H., Hoeg, L., Coté, A. G., Lin, Z., Setiaputra, D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.23.508845
Data from Rare BRIP1 Missense Alleles Confer Risk for Ovarian and Breast Cancer
Moyer, C. L., Ivanovich, J. L., Gillespie, J. L., Doberstein, R., Radke, M. R., Richardson, M. E., Kaufmann, S. H., Swisher, E. M., & Goodfellow, P. J. (2023) · doi:10.1158/0008-5472.c.6511902.v1
Nicolo, A. D., Tancredi, M., Lombardi, G., Flemma, C. C., Barbuti, S., Cristofano, C. D., Sobhian, B., Bevilacqua, G., Drapkin, R., & Caligo, M. A. (2023) · doi:10.1158/1078-0432.c.6517014
Self-citationNicolo, A. D., Tancredi, M., Lombardi, G., Flemma, C. C., Barbuti, S., Cristofano, C. D., Sobhian, B., Bevilacqua, G., Drapkin, R., & Caligo, M. A. (2023) · doi:10.1158/1078-0432.c.6517014.v1
Self-citationData from Rare BRIP1 Missense Alleles Confer Risk for Ovarian and Breast Cancer
Moyer, C. L., Ivanovich, J. L., Gillespie, J. L., Doberstein, R., Radke, M. R., Richardson, M. E., Kaufmann, S. H., Swisher, E. M., & Goodfellow, P. J. (2023) · doi:10.1158/0008-5472.c.6511902
Calvo, J. A., Fritchman, B., Hernandez, D., Persky, N. S., Johannessen, C. M., Piccioni, F., Kelch, B. A., & Cantor, S. B. (2023) · doi:10.1158/1541-7786.c.6545031.v1
Self-citationInterpretation of Missense Variants Found in Association with Cancer
Chiaraluce, R., & Consalvi, V. (2023) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0029460
A practice changing paper: biallelic inactivation of BRCA2 in Fanconi anaemia
Prepelita, D., & Tischkowitz, M. D. (2024) · BJC Reports · doi:10.1038/s44276-024-00054-w
Sriraman, S., Virtanen, V., Kukkula, A., Toriseva, M., Rokka, A., Lumiainen, A., Ahlskog, J. K., West, G., POUTANEN, M. H., Taimen, P., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.19.599365
Bi-allelic variation ofFANCJ(BRIP1) identified in premature ovarian insufficiency
He, X., Hu, M., Liu, H., Zhang, C., Liang, X., Wu, X., Yang, M., Sun, A., Yao, R., Zhao, S., et al. (2025) · Gynecology and Obstetrics Clinical Medicine · doi:10.1136/gocm-2025-000208
LncRNA LOXL1-AS1 promotes ovarian cancer progression by enhanced BRIP1 mRNA stability
Wan, S., Su, C., Ding, J. J., Liu, J., He, L., Liu, L., Peng, Q., Ni, G., & Zhu, W. (2025) · Medical Oncology · doi:10.1007/s12032-025-03055-y · Cited by 1
Ohta, T., & Nihira, N. T. (2025) · Springer eBooks · doi:10.1007/978-981-96-6779-6_1
Repair for Estrogen-Induced DNA Damage Requires BRCA1
Yamazaki, K., Takayasu, K., Masai, H., & Sasanuma, H. (2025) · Springer eBooks · doi:10.1007/978-981-96-6779-6_3
Birhiray, R. E., Birhiray, M. N., Ranger, S., & Flanders, V. L. (2025) · Case Reports in Oncological Medicine · doi:10.1155/crom/9962240
DNA end-resection is stimulated by an interaction between BRCA1 exon 11 and TOPBP1
Alonso, M. S. M., Kampen, R. A., Schreuder, A., Salas‐Lloret, D., de Ru, A. H., Garzero, V., Mesman, R. L. S., González‐Prieto, R., van Veelen, P. A., & Noordermeer, S. M. (2026) · EMBO Reports · doi:10.1038/s44319-026-00904-3
Karbassi, S., Nikolova, T., Pfeiffer, D., Nakkeeran, S., Anand, R., Frappart, P., Kuhlen, M., & Hofmann, T. G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.24.714005
Fontanilla-Ramirez, P. (2020) · theses.fr (ABES) · doi:10.70675/55998d2az7ba5z4d1ez9adezd5b9861cf0fe
Maio, N., & Rouault, T. A. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113129
Tanigawa, M., & Iwaki, T. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.21.727063
A FANCJ‐Like Protein Is Dispensable for Erythrocytic Stage Development in Plasmodium falciparum
Frighetto, R., Chakraborty, B., McGee, S. M., Danenhauer, A. R., & Kumar, S. (2026) · Cellular Microbiology · doi:10.1155/cmi/9234413
Hilgert, E., Depestel, L., Roy, N. V., Roberts, S., Durinck, K., & Speleman, F. (2026) · British Journal of Cancer · doi:10.1038/s41416-026-03569-w
Metastasis of Pancreatic Intraductal Oncocytic Papillary Neoplasm to the Ovaries
Fronk, E. D., McDowell, J. L., Yanchenko, N., Katerji, H., & Smith, A. (2026) · Case Reports in Gastrointestinal Medicine · doi:10.1155/crgm/9926744
The BRCA1-A complex: At the edge of resection and the beauty of restraint
Antonova, S. V., Mangkusaputra, V., Schreuder, A., & Noordermeer, S. M. (2026) · DNA repair · doi:10.1016/j.dnarep.2026.103964
Degrauwe, N., Tos, G. D., Trimech, M., Homicskó, K., & Digklia, A. (2026) · Genes · doi:10.3390/genes17101201
Loss of the human BRIP1 C terminus does not cause Fanconi anemia
Droste, A., Sobeck, A., Knaup, J., Popp, I., Vodopiutz, J., Janecke, A., Fiebig, B. S., Maringa, M., Faust, U., Carter, N., et al. (2026) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2026.09.009
Abbas, S. M. H., & Gladkikh, B. P. (2026) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2026.109620
BindingDB (2013) · UC San Diego · doi:10.7270/q2wh2r0q
The Role of BRCA1 in DNA Double-strand Break Repair
Dever, S. M. (2009) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/f775-c418
Guillemette, S. (2014) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2w59b
Conservation of the BRCA1 gene
Wronkowski, M. G. (2007) · RIT Scholar Works (Rochester Institute of Technology)
The interaction of CtIP with DNA damage response proteins
Abramowiçz, I. (2010) · University of Birmingham Institutional Research Archive (University of Birmingham)
Metadata
- Authors
- Cantor, S. B., Bell, D. W., Ganesan, S., Kass, E. M., Drapkin, R., Grossman, S., Wahrer, D. C. R., Sgroi, D. C., Lane, W. S., Haber, D. A., & Livingston, D. M.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Livingston, David M.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2001-04
- Volume
- 105
- Issue
- 1
- Pages
- 149-160
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2109173575
- Cited by
- 674
- References
- 61
- Citations by year
- 2026: 17 · 2025: 16 · 2024: 20 · 2023: 25 · 2022: 17 · 2021: 32 · 2020: 23 · 2019: 27 · 2018: 14 · 2017: 20 · 2016: 33 · 2015: 29 · 2014: 24 · 2013: 21 · 2012: 35
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (T32HL007627, T32-HL07627-16)
- National Cancer Institute (P50 CA 89393, P50CA089393)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- BACH1, BRCA1, protein-protein interaction, DNA double-strand break repair, homologous recombination, germline mutations, early-onset breast cancer, cancer susceptibility genes
- MeSH terms
- Adult, Binding Sites, Boston, Breast Neoplasms, Cell Line, Chromosomes, Human, Pair 17, DNA Repair, DNA Helicases, DNA-Binding Proteins, Female, Genetic Testing, Humans, Molecular Sequence Data, Protein Binding, Recombinant Fusion Proteins, Transfection, Mutagenesis, Site-Directed, Sequence Homology, Amino Acid, Protein Structure, Tertiary, BRCA1 Protein, Genetic Predisposition to Disease, RNA Helicases, Amino Acid Motifs, Spectrometry, Mass, Electrospray Ionization, Fanconi Anemia Complementation Group Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
